Eli Lilly Reports 68% Increase in Profits for Q2 2024
Q2 Revenue Surges by 36%, Driving Strong Financial Growth for Eli Lilly
Eli Lilly and Company [LLY] reported a substantial increase in profits for the second quarter of 2024 (Q2 2024), ending on June 30. The company recorded a net income of $2.97 billion, marking a significant rise from the previous quarter's earnings.
The company, headquartered in Indianapolis, Indiana, reported to SEC in an 8-K filing $3.28 earnings per share in the quarter, compared to $1.95 in the previous quarter.
Eli Lilly, a leading pharmaceutical company, reported a robust revenue of $11.30 billion for the recent period. This figure represents a substantial increase compared to the previous quarter's revenue.
In comparison to the same quarter in the previous year, Eli Lilly's revenue showed a notable surge, indicating a strong performance in the pharmaceutical industry. Additionally, the company's profit for the current quarter exhibited a significant percentage change when compared to the profit recorded in the same quarter of the previous year.
As of August 12, 2024 end of day trading.
